Questor Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Questor Pharmaceuticals ( QCOR), a biopharmaceutical company, provides prescription drugs for the treatment of auto-immune diseases. The stock is trading up 8% at $42.11 in recent trading.

Today's Volume: 2.4 million

Average Volume: 1.1 million

Volume % Change: 241%

Shares of QCOR are ripping higher today after the company announced sales of its H.P. Acthar Gel that exceeded analyst expectations. The company shipped 3,360 vial of the gel vs. 1,680 shipped in the fourth quarter of 2010.

From a technical standpoint, QCOR is starting to gap up big today back above its 50-day moving average of $42.25 on heavy volume. Traders should now watch for a sustained move and close above $42.25 to signal that this stock wants to re-test some major overhead resistance at close to $46.

I would consider it a major breakout if QCOR can take out $46 with volume in the coming days or weeks.

Questcor shows up on recent lists of 3 Low-PEG, High-Momentum Stocks and 5 Drug Stock Winners of 2011.

If you liked this article you might like

Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens

Where Are They Now? A Look Back at the Best & Worst Biotech CEOs

Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...

Using Re-Engineered Immune Cells to Kill Leukemia Induces Lasting Remissions

Stock Market Today: S&P 500 Eyes Strong Finish for 2014; Alibaba Spikes